Detalhe da pesquisa
1.
The Development of an AAV-Based CRISPR SaCas9 Genome Editing System That Can Be Delivered to Neurons in vivo and Regulated via Doxycycline and Cre-Recombinase.
Front Mol Neurosci
; 11: 413, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-30483052